10 year HCV treatment programme in people who inject drugs: No effect of recent or former injecting drug use on treatment adherence or SVR - Hallo friend NEWS AN INSPIRATION, In the article you read this time with the title 10 year HCV treatment programme in people who inject drugs: No effect of recent or former injecting drug use on treatment adherence or SVR, we have prepared well for this article you read and download the information therein. hopefully fill posts Article ECONOMY, Article HEALTH, Article POLITICS, Article SPORTS, Article TRAVELING, Article UPDATE, we write can understand. Well, happy reading.

Titre : 10 year HCV treatment programme in people who inject drugs: No effect of recent or former injecting drug use on treatment adherence or SVR
link : 10 year HCV treatment programme in people who inject drugs: No effect of recent or former injecting drug use on treatment adherence or SVR

10 year HCV treatment programme in people who inject drugs: No effect of recent or former injecting drug use on treatment adherence or SVR

Outcomes from a large 10 year hepatitis C treatment programme in people who inject drugs: No effect of recent or former injecting drug use on treatment adherence or therapeutic response
Omar Elsherif , Ciaran Bannan, Shay Keating, Susan McKiernan, Colm Bergin, Suzanne Norris

Full Text Article
Download PDF
View Online

Abstract
Background and aims

People who inject drugs (PWID) are historically viewed as having “difficult to treat” hepatitis C disease, with perceived inferior treatment adherence and outcomes, and concerns regarding reinfection risk. We evaluated for differences in treatment adherence and response to Peginterferon-alfa-2a/Ribavirin (Peg-IFNα/RBV) in a large urban cohort with and without a history of remote or recent injection drug use.

Methods

Patient data was retrospectively reviewed for 1000 consecutive patients—608 former (no injecting drug use for 6 months of therapy), 85 recent (injecting drug use within 6 months) PWID, and 307 non-drug users who were treated for chronic hepatitis C with Peg-IFNα/RBV. The groups were compared for baseline characteristics, treatment adherence, and outcome.

Results

There was no significant difference in treatment non-adherence between the groups (8.4% in PWID vs 6.8% in non-PWIDs; RR = 1.23, CI 0.76–1.99). The overall SVR rate in PWID (64.2%) was not different from non-PWIDs (60.9%) [RR = 1.05, 95% CI 0.95–1.17]. There was no significant difference in SVR rates between the groups controlling for genotype (48.4% vs 48.4% for genotype 1; 74.9 vs 73.3% for genotype 3). Former and recent PWID had similar adherence rates.

Conclusions

PWID have comparable treatment adherence and SVR rates when compared to non-drug users treated with Peg-IFNα/RBV. These data support a public health strategy of HCV treatment and eradication in PWID in the DAA era.

Published: June 21, 2017 http://ift.tt/2txwUMj
PLOS ONE

Thus articles 10 year HCV treatment programme in people who inject drugs: No effect of recent or former injecting drug use on treatment adherence or SVR

that is all articles 10 year HCV treatment programme in people who inject drugs: No effect of recent or former injecting drug use on treatment adherence or SVR This time, hopefully can provide benefits to you all. Okay, see you in another article post.

You are now reading the article 10 year HCV treatment programme in people who inject drugs: No effect of recent or former injecting drug use on treatment adherence or SVR the link address https://newsaninpiration.blogspot.com/2017/06/10-year-hcv-treatment-programme-in.html

Tweet

Subscribe to receive free email updates: